The construction company Strabag will not take over the management of AKH Vienna after all. The corresponding discussions between Strabag and the healthcare provider Viacama AG (formerly Vamed AG) have been terminated, both parties announced on Thursday. In October, the joint takeover of the entire Vamed core business (of which the AKH management is a part; note) by the construction companies Porr and Strabag had already been called off.
Viacama Retains AKH Management
Strabag announced at the time that it would continue to negotiate alone for a takeover of the AKH management. Porr declared its intention to buy the Vamed thermal spa holdings alone - the process for this is still on track, a Viacama spokesperson told APA. As was announced today, the AKH management company (VKMB Krankenhausmanagement und Betriebsführungsges.m.b.H.) remains with Viacama, which in turn is a subsidiary of the German healthcare group Fresenius.
"VIACAMA continues the management business at AKH in accordance with the existing technical management contract in close partnership with the City of Vienna," the company's statement said. Both sides did not want to comment in detail on the reasons for the end of the discussions.
Media Report on Concerns
When the end of the joint takeover by Porr and Strabag was announced in October, it was said that the negotiations could not be completed "within the desired timeframe" and, in particular, "the approval of the competent competition authority" was not available. The "Kurier" also reported in August that there were concerns in Vienna City Hall that the two construction companies wanted to secure construction contracts for renovations, new constructions, and extensions planned until 2030 worth 1.4 billion euros by purchasing the technical management of AKH Vienna.
Originally, Fresenius wanted to completely separate from its Austrian subsidiary Vamed. In February, the sale of the international Vamed project business Health Tech Engineering (HTE) to the Worldwide Hospitals Group (WWH) was completed. The Vamed rehabilitation clinics were sold to the French financial investor PAI Partners in autumn 2024. The hospital service business was integrated into the Vamed parent company Fresenius. According to Wirtschaftscompass, Vamed AG was renamed Viacama in September.
(APA/Red)
This article has been automatically translated, read the original article here.